Cardiovascular Disease
Credentials: Identifier: NPI 1457286320 · License: NY
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in…
Circulation · 2003 · 293 citations
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction…
Circulation · 2003 · 165 citations
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial
JAMA · 2004 · 156 citations
Christopher Granger
14 papers
Kenneth Mahaffey
11 papers
Stanton Shernan
7 papers
Edward Verrier
6 papers
Jerrold Levy
Judith Hochman
5 papers
Wayne Douglas Weaver
Christopher Mojcik
4 papers
Galen Wagner
3 papers
Mark Newman
Philip Sager
Eric Michelson
2 papers
